Literature DB >> 18303990

Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers.

Malgorzata Krzystek-Korpacka1, Malgorzata Matusiewicz, Dorota Diakowska, Krzysztof Grabowski, Katarzyna Blachut, Irena Kustrzeba-Wojcicka, Grzegorz Terlecki, Andrzej Gamian.   

Abstract

BACKGROUND: Accurate outcome prediction in gastroesophageal malignancies is challenging. Acute-phase response proteins (APRPs) have been claimed to be independent prognosticators, although the basis for their association with prognosis remains unexplained. We hypothesized that, similarly to pancreatic and lung cancers, changes in APRPs in gastroesophageal malignancies are associated with cachexia and accelerated angiogenesis.
METHODS: C-reactive protein (CRP), albumin and transferrin serum levels were evaluated and the Glasgow Prognostic Score (GPS) calculated. These data were compared with concentrations of circulating interleukin (IL)-1, IL-6 and IL-8, tumor necrosis factor-alpha (TNF-alpha), vascular endothelial growth factor (VEGF)-A, VEGF-C and midkine in 96 gastroesophageal cancer patients (49 with cachexia) and 42 healthy subjects.
RESULTS: Albumin and CRP levels were altered in the cancer patients, with further CRP elevation in those with cachexia. Transferrin was decreased only in the cachectic patients. The interrelationships between the APRPs were strengthened in cachexia and only then were APRPs correlated with the cytokines elevated in gastroesophageal cancer-related cachexia: IL-6, IL-8, VEGF-A and midkine. GPS corresponded well to transferrin, IL-1, IL-6, IL-8, TNF-alpha, VEGF-A and midkine concentrations.
CONCLUSIONS: Cachexia in gastroesophageal cancers is associated with changes in APRP concentrations. This, together with a direct relationship of APRPs with accelerated angiogenesis, may constitute a foundation for the association of APRPs and GPS with outcome in these malignancies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303990     DOI: 10.1515/CCLM.2008.089

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  25 in total

1.  Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis.

Authors:  Barbara Mroczko; Magdalena Groblewska; Mariusz Gryko; Bogusław Kedra; Maciej Szmitkowski
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Clinical implication of elevated CA 19-9 level and the relationship with glucose control state in patients with type 2 diabetes.

Authors:  Sun Hee Kim; Cho-Ok Baek; Kyung Ae Lee; Tae Sun Park; Hong Sun Baek; Heung Yong Jin
Journal:  Endocrine       Date:  2013-10-10       Impact factor: 3.633

Review 3.  The impact of exercise training on adipose tissue remodelling in cancer cachexia.

Authors:  Rita Ferreira; Rita Nogueira-Ferreira; Rui Vitorino; Lúcio Lara Santos; Daniel Moreira-Gonçalves
Journal:  Porto Biomed J       Date:  2017-06-11

4.  Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer.

Authors:  Sumanta Dutta; Andrew B C Crumley; Grant M Fullarton; Paul G Horgan; Donald C McMillan
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

5.  Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer.

Authors:  Tadahiro Nozoe; Tomohiro Iguchi; Eisuke Adachi; Akito Matsukuma; Takahiro Ezaki
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

6.  Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.

Authors:  Yan Xiao; Ying-Kun Ren; Hui-Jun Cheng; Li Wang; Su-Xia Luo
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

7.  Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.

Authors:  Kyung A Kwon; Sung Hyun Kim; Sung Yong Oh; Suee Lee; Jin-Yeong Han; Kyeong Hee Kim; Ri Young Goh; Hong Jo Choi; Ki Jae Park; Mee Sook Roh; Hyo-Jin Kim; Hyuk-Chan Kwon; Jong Hoon Lee
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

8.  The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers.

Authors:  Campbell S D Roxburgh; Jonathan M Salmond; Paul G Horgan; Karin A Oien; Donald C McMillan
Journal:  J Gastrointest Surg       Date:  2009-09-19       Impact factor: 3.452

9.  Modified glasgow prognostic score predicting high conversion ratio in opioid switching from oral oxycodone to transdermal fentanyl in patients with cancer pain.

Authors:  Shu-Shan Jia; Li Shang; Ming-E Li; Dong-Mei Zhao; Wen-Hua Xu; Yao-Qi Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.

Authors:  R J E Skipworth; D A C Deans; B H L Tan; K Sangster; S Paterson-Brown; D A Brown; M Hunter; S N Breit; J A Ross; K C H Fearon
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.